MAGICL BNP (CLIA) is intended for the in vitro quantitative determination of human B-type natriuretic peptide (BNP) in human plasma and whole blood samples.

Key Features Instant Testing  2-15 minutes/test 5 seconds/test for simple samples Optimized Operation One-step test Auto-recognition of test items Optional barcode scanner Use-friendly Design 7 inch touch screen Communication port USB / LAN Optional lithium battery Application Scenarios ICU Emergency Room Clinic Test Menu Technical Specifications Methodology: Colloidal gold Dimensions: 220 mm (D) *230 mm (W) *98 mm (H) Weight: 1.5 kg Sample Type: Serum, plasma, whole blood, urine, stool Storage Capacity: 10000 data Language: English/Chinese/Spanish Screen: 7 inch touch screen Printer: Internal thermal printer Certificate: CE, ISO  

This product is intended for in vitro diagnostic use in the quality control of Anti-HBs quant, Anti-HBe, Anti-HBe quant, Anti-HBc, Anti-HBc quant, HIV Ag/Ab Combo on the Getein Platforms.

MAGICL Myo (CLlA) is intended for the in vitro quantitative determination of Myoglobin (Myo) in human serum, plasma or whole blood.

This product is intended for in vitro diagnostic use in the quality control of Inflammation (CRP, SAA, PCT and IL-6) on the Getein Platforms.

MAGICL CK-MB (CLIA) is intended for the in vitro quantitative determination of Creatine Kinase-MB (CK-MB) in human serum, plasma or whole blood samples.

This product is intended for in vitro diagnostic use in the quality control of CG, LN, CIV, PIIIP N-P and HA on the Getein Platforms.

MAGICL D-Dimer (CLlA) is intended for the in vitro quantitative determination of D-Dimer (DD) in human plasma or whole blood.